Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
申请人:——
公开号:US20030073849A1
公开(公告)日:2003-04-17
The present invention relates to compounds of Formula (I) and pharmaceutically acceptable salts or solvates thereof and pharmaceutically acceptable formulations comprising said compounds
1
useful for the treatment of depression, anxiety disorders, premature ejaculation, chronic pain, obsessive-compulsive disorder, feeding disorders, premenstrual dysphoric disorder, panic disorders and psychotic disorders including bipolar disorder and schizophrenia.
Copper-diphosphine complex catalysts for N-formylation of amines under 1 atm of carbon dioxide with polymethylhydrosiloxane
作者:Ken Motokura、Naoki Takahashi、Daiki Kashiwame、Sho Yamaguchi、Akimitsu Miyaji、Toshihide Baba
DOI:10.1039/c3cy00375b
日期:——
as compared to a bidentate ligand connected with a propyl chain and a monodentate ligand. Among these diphosphines, ligands with alkyl functionalities, such as isopropyl and cyclohexyl groups, produced better results than the phenyl group. Not only cyclic secondary amines, but also linear secondary amines and aromatic and aliphatic primary amines were found to be reactive substrates. In the case of
Potent and Selective Triazole-Based Inhibitors of the Hypoxia-Inducible Factor Prolyl-Hydroxylases with Activity in the Murine Brain
作者:Mun Chiang Chan、Onur Atasoylu、Emma Hodson、Anthony Tumber、Ivanhoe K. H. Leung、Rasheduzzaman Chowdhury、Verónica Gómez-Pérez、Marina Demetriades、Anna M. Rydzik、James Holt-Martyn、Ya-Min Tian、Tammie Bishop、Timothy D. W. Claridge、Akane Kawamura、Christopher W. Pugh、Peter J. Ratcliffe、Christopher J. Schofield
DOI:10.1371/journal.pone.0132004
日期:——
As part of the cellular adaptation to limiting oxygen availability in animals, the expression of a large set of genes is activated by the upregulation of the hypoxia-inducible transcription factors (HIFs). Therapeutic activation of the natural human hypoxic response can be achieved by the inhibition of the hypoxia sensors for the HIF system, i.e. the HIF prolyl-hydroxylases (PHDs). Here, we report studies on tricyclic triazole-containing compounds as potent and selective PHD inhibitors which compete with the 2-oxoglutarate co-substrate. One compound (IOX4) induces HIFα in cells and in wildtype mice with marked induction in the brain tissue, revealing that it is useful for studies aimed at validating the upregulation of HIF for treatment of cerebral diseases including stroke.